New Results
Amelioration of muscular dystrophy phenotype in mdx mice by inhibition of Flt1
View ORCID ProfileMayank Verma, Yuko Shimizu-Motohashi, Yoko Asakura, James Ennen, Jennifer Bosco, Zhiwei Zou, Guo-Hua Fong, Serene Josiah, Dennis Keefe, Atsushi Asakura
doi: https://doi.org/10.1101/609735
Mayank Verma
aMedical Scientist Training Program, University of Minnesota Medical School, Minneapolis, MN, USA
bStem Cell Institute, University of Minnesota Medical School, Minneapolis, MN, USA
cPaul & Sheila Wellstone Muscular Dystrophy Center, University of Minnesota Medical School, Minneapolis, MN, USA
dDepartment of Neurology, University of Minnesota Medical School, Minneapolis, MN, USA
Yuko Shimizu-Motohashi
bStem Cell Institute, University of Minnesota Medical School, Minneapolis, MN, USA
cPaul & Sheila Wellstone Muscular Dystrophy Center, University of Minnesota Medical School, Minneapolis, MN, USA
dDepartment of Neurology, University of Minnesota Medical School, Minneapolis, MN, USA
Yoko Asakura
bStem Cell Institute, University of Minnesota Medical School, Minneapolis, MN, USA
cPaul & Sheila Wellstone Muscular Dystrophy Center, University of Minnesota Medical School, Minneapolis, MN, USA
dDepartment of Neurology, University of Minnesota Medical School, Minneapolis, MN, USA
James Ennen
bStem Cell Institute, University of Minnesota Medical School, Minneapolis, MN, USA
cPaul & Sheila Wellstone Muscular Dystrophy Center, University of Minnesota Medical School, Minneapolis, MN, USA
dDepartment of Neurology, University of Minnesota Medical School, Minneapolis, MN, USA
Jennifer Bosco
fShire Human Genetic Therapies, Inc., Lexington, MA, USA, a member of the Takeda group of companies.
Zhiwei Zou
fShire Human Genetic Therapies, Inc., Lexington, MA, USA, a member of the Takeda group of companies.
Guo-Hua Fong
eCenter for Vascular Biology, University of Connecticut Health Center, University of Connecticut School of Medicine, Farmington, CT, USA
Serene Josiah
fShire Human Genetic Therapies, Inc., Lexington, MA, USA, a member of the Takeda group of companies.
Dennis Keefe
fShire Human Genetic Therapies, Inc., Lexington, MA, USA, a member of the Takeda group of companies.
Atsushi Asakura
bStem Cell Institute, University of Minnesota Medical School, Minneapolis, MN, USA
cPaul & Sheila Wellstone Muscular Dystrophy Center, University of Minnesota Medical School, Minneapolis, MN, USA
dDepartment of Neurology, University of Minnesota Medical School, Minneapolis, MN, USA
Article usage
Posted April 21, 2019.
Amelioration of muscular dystrophy phenotype in mdx mice by inhibition of Flt1
Mayank Verma, Yuko Shimizu-Motohashi, Yoko Asakura, James Ennen, Jennifer Bosco, Zhiwei Zou, Guo-Hua Fong, Serene Josiah, Dennis Keefe, Atsushi Asakura
bioRxiv 609735; doi: https://doi.org/10.1101/609735
Subject Area
Subject Areas
- Biochemistry (11730)
- Bioengineering (8743)
- Bioinformatics (29179)
- Biophysics (14964)
- Cancer Biology (12080)
- Cell Biology (17399)
- Clinical Trials (138)
- Developmental Biology (9417)
- Ecology (14174)
- Epidemiology (2067)
- Evolutionary Biology (18294)
- Genetics (12233)
- Genomics (16791)
- Immunology (11858)
- Microbiology (28051)
- Molecular Biology (11575)
- Neuroscience (60919)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4955)
- Plant Biology (10422)
- Synthetic Biology (2881)
- Systems Biology (7338)
- Zoology (1650)